Early Recurrence of Pancreatic Cancer after Resection and During Adjuvant Chemotherapy

BACKGROUND/AIM: Adjuvant chemotherapy for 6 months is the current standard of care after potentially curative resection of pancreatic cancer and yields an overall survival of 15–20 months. Early tumor recurrence before or during adjuvant chemotherapy has not been evaluated so far. These patients may...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Richard, Breidert, Matthias, Keck, Tobias, Makowiec, Frank, Lohrmann, Christian, Harder, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326972/
https://www.ncbi.nlm.nih.gov/pubmed/22421717
http://dx.doi.org/10.4103/1319-3767.93815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326972/
https://www.ncbi.nlm.nih.gov/pubmed/22421717
http://dx.doi.org/10.4103/1319-3767.93815

Ejemplares similares